CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and the University of Wisconsin (UW) School ...

Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.

Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...

The Vilcek Foundation is now accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science through May 4, 2026. These $50,000 cash awards are given each year to three ...

In the biotech sphere, ARK continued its accumulation of CRISPR Therapeutics AG (NASDAQ:CRSP) by acquiring 37,075 shares worth $1.97 million. This purchase is part of a broader strategy, as ARK has ...

The agricultural sector is evolving thanks to new technology necessitated by a growing global population and the pressures of ...

Cathie Wood’s ARK Invest ETFs continued a similar trend from the last week, rotating further into crypto-linked platforms, ...

Euronews Tech Talks goes beyond discussions to explore the impact of new technologies on our lives. View on euronews ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Amyotrophic Lateral Sclerosis Therapeutics Market size & share revenue was ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...